Breakthrough at ACG 2013: Oral-Only Treatment for Chronic Hepatitis C

Data from pivotal international phase III clinical trials showed superior efficacy, safety, and convenience for a new wave of direct-acting oral agents. The breakthrough will benefit physicians in all practice settings, including primary care.
Source: Consultant Live - Category: Primary Care Source Type: news